Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD07805/47 vs Azelaic Acid in Rosacea Erythema
NCT01659853Phase 3Completed
- Sponsor
- Galderma
- Start
- Sep 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Onreltea in rosacea, sponsored by Galderma. Started Sep 2012; status: completed.
02
Drugs
Onreltea
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT01659853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01659853.